If you’re a practicing rheumatologist who keeps up with field news by subscribing to Rheum Now and Cleveland Clinic’s Rheumatology Daily Briefing e-newsletters, then you’ve probably heard a lot about the Annual European Congress of Rheumatology recently.
What is the Annual European Congress of Rheumatology, you may ask? Every year, The European League Against Rheumatism (EULAR) holds this forum so rheumatology professionals across the European Union can connect with patient organizations and can learn and engage with other professionals in rheumatology. As an organization that represents the patient, healthcare professional and professional societies of rheumatology, EULAR holds this forum help achieve progress in the care of people who suffer from various rheumatic diseases.
This year’s congress took place in Madrid, Spain just a few short weeks ago, and everyone around the world is still buzzing about the presentations and findings that were on display. If you keep up with my blogs, you might have read my coverage about “Smoke Exposure in Childhood Can Boost Chances of Getting RA” and “Medicines May Help to Prevent Arthritis” that were presented at the forum. Additional newsworthy topics that are worth mentioning are a new prediction tool that can reduce the cost of rheumatoid arthritis treatment and new effective treatments that are in development for psoriatic arthritis patients.
This blog was originally posted on Micha Abeles’ other website. To read the rest of the blog, please click here.